Zebadiah Kimmel

VisionGate, Inc. provides in-vitro automated 3D cell structure and analysis solutions. It focuses on early detection and prevention of lung cancer. The firm’s attendees include surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic research scientists, nurses and allied health professionals and patients. The company was founded by Alan C. Nelson and is headquartered in Phoenix, AZ.

NinePoint Medical, Inc. develops and manufactures medical devices. It designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, evaluation of human tissue microstructure. The company is headquartered in Bedford, MA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Part of Carl-Zeiss-Stiftung, Carl Zeiss, Inc. is a company that manufactures optical lenses. The company is based in Maple Grove, MN.

LightLab Imaging, Inc. develops optical coherence tomography technology. Its technology is used to manufacture medical products for imaging and tissue characterization. The company was founded in February 1998 and is headquartered in Westford, MA.

Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH.

Intelligent Medical Devices, Inc. engages in the designs development and manufacture of platform-agnostic, regulatory-cleared molecular diagnostic tests. The company was founded by Alice A. Jacobs Nesselrodt in 2000 and is headquartered in Waltham, MA.

Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation.

Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA.

GreyBird Ventures LLC (GreyBird Ventures) is a venture capital firm founded in 2013 by Tom Miller, Scott Gazelle and Mike Devlin. The firm is headquartered in Concord, Massachusetts.

Ceres Nanosciences, Inc. provides research, development, and commercialization of innovative sample preparation products, based on its proprietary technology. The company was founded by Emanuel F. Petrioin III, Lance Liota and Ross M. Dunlap in 2008 and is headquartered in Manassas, VA.

GenetikaPlus Ltd. develops precision medicine tool for depressive disorder patients. It creates personalized solution using biological, medical, and genetic data. The company was founded by Talia Cohen-Solal and Daphna Laifenfeld and is headquartered in Jerusalem, Israel.

Angstrom Bio, Inc. is a biotechnology company based in the United States that specializes in the study, diagnosis, and treatment of disease. The company is based in Austin, TX. The company's focus is on the development and deployment of AMpD, a technology that aims to deliver over 1,000,000 test results per day in 2021. The company applies machine learning and novel nucleotide chemistry to their work, with the goal of using machine intelligence for human health. The company was founded by David J. States, and the CEO is Carlos Santos.